Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
PAVmed Inc. PAVM
$0.52
+$0 (0.93%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
51178296.00000000
-
week52high
2.34
-
week52low
0.35
-
Revenue
377000
-
P/E TTM
-1
-
Beta
0.84325200
-
EPS
-1.15000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:00
Описание компании
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Lake Street | Buy | Buy | 17 авг 2022 г. |
| Cantor Fitzgerald | Overweight | 30 мар 2021 г. | |
| Ascendiant Capital | Buy | 05 ноя 2020 г. | |
| Lake Street | Buy | 13 окт 2020 г. | |
| Maxim Group | Buy | 28 июн 2018 г. | |
| Lake Street | Buy | Buy | 18 янв 2023 г. |
| Cantor Fitzgerald | Neutral | Overweight | 20 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sparks Ronald M | A | 450000 | 450000 | 30 янв 2023 г. |
| Harvey Joan B | A | 450000 | 450000 | 30 янв 2023 г. |
| White Debra | A | 450000 | 450000 | 30 янв 2023 г. |
| Glennon Michael J | A | 450000 | 450000 | 30 янв 2023 г. |
| Baxter Timothy E | A | 450000 | 450000 | 30 янв 2023 г. |
| Cox James L | A | 450000 | 450000 | 30 янв 2023 г. |
| Glennon Michael J | A | 250000 | 100000 | 07 дек 2022 г. |
| Glennon Michael J | A | 150000 | 88000 | 06 дек 2022 г. |
| Glennon Michael J | A | 62000 | 62000 | 05 дек 2022 г. |
| Gordon Michael Adam | A | 400000 | 400000 | 07 июн 2022 г. |
Новостная лента
PAVmed Inc. (PAVM) Upgraded to Strong Buy: Here's What You Should Know
Zacks Investment Research
17 мар 2023 г. в 13:45
PAVmed Inc. (PAVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
PAVmed Inc. (PAVM) Q4 2022 Earnings Call Transcript
Seeking Alpha
15 мар 2023 г. в 12:51
PAVmed Inc. (NASDAQ:PAVM ) Q4 2022 Earnings Conference Call March 15, 2023 8:30 AM ET Company Participants Michael Parks – Vice President, Investor Relations Lishan Aklog – Chairman and CEO Dennis McGrath – Chief Financial Officer Conference Call Participants Ross Osborn – Cantor Fitzgerald Frank Takkinen – Lake Street Capital Anthony Vendetti – Maxim Group Ed Woo – Ascendiant Capital Operator Welcome to the PAVmed's Business Update and Fourth Quarter 2022 Financial Results Conference Call. At this time all participants are in a listen-only mode.
PAVmed Inc. (PAVM) Q3 2022 Earnings Call Transcript
Seeking Alpha
15 ноя 2022 г. в 22:07
PAVmed Inc. (NASDAQ:PAVM ) Q3 2022 Earnings Conference Call November 15, 2022 4:30 PM ET Company Participants Adrian Miller - VP, IR Lishan Aklog - Chairman and CEO Dennis McGrath - President and CFO Conference Call Participants Charlie Montang - Lake Street Capital Markets Edward Woo - Ascending Capital Markets LLC Anthony Vendetti - Maxim Group Operator Ladies and gentlemen, greetings and welcome to the PAVmed Inc. Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022
Business Wire
03 ноя 2022 г. в 08:25
NEW YORK--(BUSINESS WIRE)---- $PAVM #1x1meetings--PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical device company today announced that the Company will host a business update conference call and webcast on Tuesday, November 15, 2022, at 4:30 PM EDT.
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022
Business Wire
02 ноя 2022 г. в 08:25
NEW YORK--(BUSINESS WIRE)-- #CheckYourFoodTube--Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, a majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ), today announced that the Company will host a business update conference call and webcast on Monday, November 14, 2022, at 4:30 PM EDT.